(Q70408145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

M Katano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

H Yamamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

T Mizoguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

T Hisatsugu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

198-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00205440

11 October 2019

exact match

0 references

cites work

Anti-tumour therapy by induction of endogenous tumour necrosis factor

1 reference

12 December 2020

In vitro production of immune interferon (IFN gamma) by murine spleen cells when different sensitizing antigens are used in vivo and in vitro

1 reference

12 December 2020

Interferon-gamma induction in human peripheral blood mononuclear cells by OK-432, a killed preparation of Streptococcus pyogenes

1 reference

12 December 2020

Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells

1 reference

12 December 2020

Rabbit tumor necrosis factor: mechanism of action.

1 reference

12 December 2020

Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock

1 reference

12 December 2020

Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.

1 reference

12 December 2020

Streptococcal preparation OK-432-induced interferon in human leukocytes: purification and characterization

1 reference

12 December 2020

Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432

1 reference

12 December 2020

Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes

1 reference

12 December 2020

The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis

1 reference

12 December 2020

Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432

1 reference

12 December 2020

Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma)

1 reference

12 December 2020

Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival

1 reference

12 December 2020

Lymphocyte in vitro cytotoxicity: mechanism of lymphotoxin-induced target cell destruction

1 reference

12 December 2020

Antitumor effect of the streptococcal preparation OK-432 in a murine model of ovarian cancer.

1 reference

12 December 2020

Augmentation of interleukin 1 and interleukin 2 production by OK-432

1 reference

12 December 2020

Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation

1 reference

12 December 2020

Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

1 reference

12 December 2020

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction

1 reference

12 December 2020

Brief Communication: Tumor Suppression by a Lymphokine Released Into the Circulation of Mice With Delayed Hypersensitivity 2

1 reference

12 December 2020

Neutrophil-mediated tumor cell destruction in cancer ascites

1 reference

12 December 2020

Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3141056%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference